Cargando…
Risk of cancer in patients with heart failure who use digoxin: a 10-year follow-up study and cell-based verification
Heart failure (HF) is the leading cause of death in the world and digoxin remains one of the oldest therapies for HF. However, its safety and efficacy have been controversial since its initial use and there is uncertainty about its long-term efficacy and safety. Recently, the repositioning of cardia...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Impact Journals LLC
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5546474/ https://www.ncbi.nlm.nih.gov/pubmed/28496002 http://dx.doi.org/10.18632/oncotarget.17410 |